Cannasouth

Cannasouth is a biopharmaceutical research and development company based in Waikato, New Zealand. The company has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The goal is the development of next-generation cannabinoid medicines that support patients' health outcomes and improve quality of life. Cannasouth products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.


Company Details

Registered Office: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Postal Address: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Telephone: +64-7-949-8393
Facsimile: n/a
Website: https://cannasouth.co.nz/
First Listed: 19/06/2019
Balance Date: 31 December
AGM: 30/06/2023

Directors and Executives

Colin Foster
CFO / Company Secretary
Anthony Ho
Independent Chairman
Mark Lucas
Chief Executive Officer
Christine Pears
Independent Non-Executive Director
Mark Scapens
Non-Executive Director

Announcements

Title Date Type
Cannasouth signs Deed of Company Arrangement Wed, Jul 03 2024 08:51 am ADMIN
Subsidiaries parties to Deed of Company Arrangement Mon, Jul 01 2024 12:42 pm ADMIN
Cannasouth Announces Resignation of Director Mon, Jun 17 2024 04:08 pm ADMIN
Cannasouth Announces Outcome of Watershed Meeting Fri, Jun 07 2024 04:55 pm GENERAL
Outcome of Watershed Meeting for Cannasouth Bioscience Ltd Fri, Jun 07 2024 04:45 pm GENERAL
Cannasouth Announces Watershed Meeting Wed, May 29 2024 03:56 pm MEETING
Cannasouth Announces Extension of Watershed Meeting Thu, May 02 2024 04:32 pm MEETING
Cannasouth Announces Termination of Employment of COO Mon, Apr 15 2024 04:08 pm ADMIN
Cannasouth Announces CEO Resignation Thu, Apr 11 2024 10:23 am ADMIN
CBD – Suspension of trading of Securities Thu, Mar 28 2024 05:39 pm HALT

Major Holdings Announcements

Date Name No. Held % Current
15/08/23 Nicholas Jon Foreman 23,605,360 17.61 7.36
26/06/23 Mark James Scapens 23,887,591 - 7.45
08/06/23 Mark Lucas 28,029,435 27.60 8.74
11/03/20 Adam Sorensen 5,165,563 6.14 4.89

Director’s Interests Announcements

Date Name No. Held % Details Other
13/02/24 Anthony Ho 2,700,000 - - -
19/12/23 Christine Pears 210,000 - - -
22/06/23 Gregory Misson 1,136,067 - - -
08/06/23 Hilary Webber. 2,710,425 - - -
15/09/22 Juliet Hull 28,766 - - -
10/08/21 Colin Foster 250,000 - - -
23/10/20 Conor English 4,741 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 13/02/2024


Markets News

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.

These shares are 'priced for awful'
Markets Market close

NZ sharemarket drifts lower

The S&P/NZX 50 Index closed at 11,776.73, easing 12.65 points or 0.11%.

Graham Skellern 02 Jul 2024
NZ sharemarket drifts lower
Markets

Aust shares dip again as traders digest RBA minutes

The ASX200 was down 0.2% at midday, on track for its second day of modest losses.

AAP 02 Jul 2024
Aust shares dip again as traders digest RBA minutes